| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPHEART.2000.279.3.H1319 |
| P698 | PubMed publication ID | 10993799 |
| P2093 | author name string | C R Alving | |
| J Szebeni | |||
| G L Stahl | |||
| M Bodo | |||
| R Bünger | |||
| L Baranyi | |||
| M Basta | |||
| D S Morse | |||
| S Savay | |||
| P433 | issue | 3 | |
| P921 | main subject | pulmonary hypertension | Q1128595 |
| P304 | page(s) | H1319-28 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction | |
| P478 | volume | 279 |
| Q64101446 | Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice |
| Q35691719 | Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. |
| Q92783014 | Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes |
| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q91770164 | CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial |
| Q34655402 | Cholesterol domains enhance transfection |
| Q89687200 | Dog-specific hemorrhagic changes induced by liposomal formulations, in the liver and the gallbladder |
| Q36079949 | Group B Streptococcus, phospholipids and pulmonary hypertension |
| Q34981943 | Group B streptococcal phospholipid causes pulmonary hypertension |
| Q81453578 | Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes |
| Q38564991 | Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management |
| Q92920924 | Immunological and Toxicological Considerations for the Design of Liposomes |
| Q33652247 | Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid |
| Q81008685 | Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia |
| Q57815916 | Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization |
| Q30366990 | Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. |
| Q36868273 | Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions |
| Q35110669 | Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model |
| Q47571555 | Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate |
| Q64086707 | Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis |
| Q37224349 | Magnetic resonance spectroscopy for evaluation of liposome-encapsulated hemoglobin as a resuscitation fluid |
| Q30405605 | Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells |
| Q91640484 | PEGylated liposomes: immunological responses |
| Q36792020 | Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo |
| Q42843716 | Protein-based blood substitutes: recent attempts at controlling pro-oxidant reactivity with and beyond hemoglobin |
| Q36744853 | Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. |
| Q33983629 | Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study |
| Q35143269 | Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO |
| Q81845072 | Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo |
| Q48251699 | The Emulsified PFC Oxycyte® Improved Oxygen Content and Lung Injury Score in a Swine Model of Oleic Acid Lung Injury (OALI). |
| Q21245483 | Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial |
Search more.